Home » Stocks » Medpace Holdings

Medpace Holdings, Inc. (MEDP)

Stock Price: $124.84 USD 2.82 (2.31%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 4.42B
Revenue (ttm) 882.00M
Net Income (ttm) 106.85M
Shares Out 35.41M
EPS (ttm) 2.83
PE Ratio 44.11
Forward PE 31.95
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $124.84
Previous Close $122.02
Change ($) 2.82
Change (%) 2.31%
Day's Open 121.79
Day's Range 121.37 - 125.00
Day's Volume 225,823
52-Week Range 58.72 - 144.49

More Stats

Market Cap 4.42B
Enterprise Value 4.37B
Earnings Date (est) Nov 2, 2020
Ex-Dividend Date n/a
Shares Outstanding 35.41M
Float 27.35M
EPS (basic) 2.97
EPS (diluted) 2.83
FCF / Share 5.31
Dividend n/a
Dividend Yield n/a
Earnings Yield 2.27%
FCF Yield 4.25%
Payout Ratio n/a
Shares Short 2.62M
Short Ratio 10.37
Short % of Float 24.39%
Beta 1.32
PE Ratio 44.11
Forward PE 31.95
P/FCF Ratio 23.53
PS Ratio 5.01
PB Ratio 5.73
Revenue 882.00M
Operating Income 131.74M
Net Income 106.85M
Free Cash Flow 187.84M
Net Cash 45.92M
Net Cash / Share 1.30
Gross Margin 61.22%
Operating Margin 14.94%
Profit Margin 12.10%
FCF Margin 21.30%
ROA 7.36%
ROE 15.31%
ROIC 410.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (7)

Buy 2
Overweight 0
Hold 5
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

$118.40*
(-5.16% downside)
Low
113
Current: $124.84
High
125
Target: 118.40
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue861705436422359
Revenue Growth22.19%61.55%3.46%17.41%-
Gross Profit246216175172156
Operating Income12710164.8652.4920.56
Net Income10073.1939.1213.43-8.67
Shares Outstanding35.8835.5539.0635.6931.35
Earnings Per Share2.671.970.980.37-0.28
EPS Growth35.53%101.02%164.86%--
Operating Cash Flow20215797.3991.7385.87
Capital Expenditures-17.91-16.02-11.72-13.54-6.47
Free Cash Flow18414185.6678.2079.41
Cash & Equivalents13223.2826.4937.4117.74
Total Debt45.2179.72222164378
Net Cash / Debt86.71-56.44-195-126-360
Assets1,143968951979984
Liabilities417378447368571
Book Value726590504611413
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Medpace Holdings, Inc.
Country United States
Employees 3,400
CEO August James Troendle

Stock Information

Ticker Symbol MEDP
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: MEDP
IPO Date August 11, 2016

Description

Medpace Holdings, Inc., a clinical contract research organization, provides scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries worldwide. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is headquartered in Cincinnati, Ohio.